Results 1-31 of 31 (Search time: 0.009 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2023 | Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies | Petrick, JL; Florio, AA; Zen, J; Wang, Y; Gewirtz, AT; Pfeiffer, RM; Loftus, S; Inglefield, J; Koshiol, J; Yang, B; Yu, K; Hildesheim, A; Chen, CJ ; Yang, HI ; Lee, MH; McGlynn, KA | INTERNATIONAL JOURNAL OF CANCER 153(1), 44-53 | |||
2 | 2023 | Rapid decline rather than absolute level of HBsAg predicts its seroclearance in untreated chronic hepatitis B patients from Taiwanese communities | Lin, HC; Liu, J; Pan, MH; Lee, MH; Batrla-Utermann, R; Lu, SN; Jeng, WJ; Yang, HI ; Chen, CJ | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 14(8), e00586 | |||
3 | 2022 | Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B | Hu, HH; Jeng, WJ; Pan, MH; Luo, WS; Chang, CL; Huang, YT ; Su, CY; Chiang, CT; Jen, CL; Chien, YC; Lu, SN; Wang, LY; Huang, LR; Lee, MH; Liu, J; Nguyen, MH; Chen, CJ ; Yang, HI | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 55(5), 558-567 | |||
4 | 2022 | Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort | Argirion, I; Brown, J; Jackson, S; Pfeiffer, RM; Lam, TK; O'Brien, TR; Yu, KJ; McGlynn, KA; Petrick, JL; Pinto, LA; Chen, CJ ; Hildesheim, A; Yang, HI ; Lee, MH; Koshiol, J | Cancers 14(21), 5280 | |||
5 | 2021 | Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B | Argirion, I; Pfeiffer, RM; Lam, TK; O'Brien, TR; Yu, K; McGlynn, KA; Petrick, JL; Pinto, L; Chen, CJ ; Lee, MH; Hildesheim, A; Yang, HI ; Koshiol, J | Scientific reports 11, 21194 | |||
6 | 2021 | Genetic variants associated with serum alanine aminotransferase levels among patients with hepatitis C virus infection: A genome-wide association study | Liu, PC; Chan, C; Huang, YH; Chen, YJ; Liao, SF; Lin, YJ; Huang, C; Lu, SN; Jen, CL; Wang, LY; Yang, HI ; Shen, CY ; Chen, CJ ; Lee, MH | Journal of viral hepatitis 28(9), 1265-1273 | |||
7 | 2021 | Postdiagnosis aspirin use associated with decreased biliary tract cancer-specific mortality in a large nationwide cohort | Liao, SF; Koshiol, J; Huang, YH; Jackson, SS; Huang, YH; Chan, C; Huang, C; Liu, PC; Chen, YJ; Hsieh, RJ; Huang, CP; Lu, SN; Chen, CJ ; Shen, CY ; Lee, MH | HEPATOLOGY 74(4), 1994-2006 | |||
8 | 2021 | Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan. | Lee, MH; Huang, YH; Coghill, AE; Liu, Z; Yu, KJ; Hsu, WL; Chien, YC; Wang, CP; Chen, TC; Chen, CJ ; Hildesheim, A | JOURNAL OF INFECTIOUS DISEASES 223(3), 441-444 | |||
9 | 2021 | HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma. | Liu, Z; Huang, CJ; Huang, YH; Pan, MH; Lee, MH; Yu, KJ; Pfeiffer, RM; Viard, M; Yuki, Y; Gao, X; Carrington, M; Chen, CJ ; Hildesheim, A; Yang, HI | The Journal of Infectious Diseases 224(10), 1796-1805 | |||
10 | 2021 | Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals | Koshiol, J; Argirion, I; Liu, Z; Kim, Lam, T; O'Brien, TR; Yu, K; McGlynn, KA; Petrick, JL; Pinto, L; Chen, CJ ; Hildesheim, A; Pfeiffer, RM; Lee, MH; Yang, HI | Alimentary pharmacology & therapeutics 54(6), 833-842 | |||
11 | 2020 | Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies | Petrick, JL; Florio, AA; Koshiol, J; Pfeiffer, RM; Yang, B; Yu, K; Chen, CJ ; Yang, HI ; Lee, MH; McGlynn, KA | International journal of cancer 147(10), 2743-2753 | |||
12 | 2020 | Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model | Chien, LH; Chen, CH; Chen, TY; Chang, GC; Tsai, YH; Hsiao, CF; Chen, KY; Su, WC; Wang, WC; Huang, MS; Chen, YM; Chen, CY; Liang, SK; Chen, CY; Wang, CL; Lee, MH; Chung, RH; Tsai, FY; Hu, JW; Katki, HA; Chatterjee, N; Chanock, SJ; Rothman, N; Lan, Q; Yang, PC; Chen, CJ ; Chang, IS; Hsiung, CA | Cancer Epidemiology, Biomarkers & Prevention 29(2), 452-459 | |||
13 | 2019 | Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection. | Liu, J; Hu, HH; Chang, CL; Jen, CL; Lee, MH; Lu, SN; Wang, LY; Yuan, Q; Xia, NS; Sugiyama, M; Nishida, N; Mizokami, M; Chen, CJ ; Chen, PJ; Yang, HI | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 17(7), 1413-1415 | |||
14 | 2019 | Level of hepatitis B (HB) core antibody associates with seroclearance of HBV DNA and HB surface antigen in HB e antigen-seronegative patients. | Hu, HH; Liu, J; Chang, CL; Jen, CL; Lee, MH; Lu, SN; Wang, LY; Quan, Y; Xia, NS; Chen, CJ ; Chen, PJ; Yang, HI | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 17(1), 172-172-181.e1 | |||
15 | 2019 | Taiwan's health-care system and administration are independent of China | Tsai, DH; Lee, MH; Chen, DS; Liaw, YF; Yang, PC; Huang, YH; Chen, CJ | Lancet (London, England) 394(10208), 1516 | |||
16 | 2018 | A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements. | Lin, YJ; Chang, CL; Chen, LC; Hu, HH; Liu, J; Korenaga, M; Huang, YH; Jen, CL; Su, CY; Nishida, N; Sugiyama, M; Lu, SN; Wang, LY; Yuan, Y; L'Italien, G; Yang, HI ; Mizokami, M; Chen, CJ ; Lee, MH | Clinical and translational gastroenterology 9(9), e183 | |||
17 | 2018 | Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. | Chu, YJ; Yang, HI ; Wu, HC; Lee, MH; Liu, J; Wang, LY; Lu, SN; Jen, CL; You, SL; Santella, RM; Chen, CJ | EUROPEAN JOURNAL OF CANCER 94, 37-46 | |||
18 | 2018 | Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study. | Lee, MH; Huang, YH; Chen, HY ; Khor, SS; Chang, YH; Lin, YJ; Jen, CL; Lu, SN; Yang, HI; Nishida, N; Sugiyama, M; Mizokami, M; Yuan, Y; L'Italien, G; Tokunaga, K; Chen, CJ | Hepatology (Baltimore, Md.) 67(2), 651-661 | |||
19 | 2017 | Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study | Lai, TS; Lee, MH; Yang, HI; You, SL; Lu, SN; Wang, LY; Yuan, Y; L'Italien, G; Chien, KL; Chen, CJ | Hepatology (Baltimore, Md.) 66(3), 784-793 | |||
20 | 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee, MH; Huang, CF; Lai, HC; Lin, CY; Dai, CY; Liu, CJ; Wang, JH; Huang, JF; Su, WP; Yang, HC; Kee, KM; Yeh, ML; Chuang, PH; Hsu, SJ; Huang, CI; Kao, JT; Chen, CC; Chen, SH; Jeng, WJ; Yang, HI; Yuan, Y; Lu, SN; Sheen, IS; Liu, CH; Peng, CY; Kao, JH; Yu, ML; Chuang, WL; Chen, CJ | Scientific reports 7, 3718 | |||
21 | 2017 | High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease | Lai, TS; Lee, MH; Yang, HI; You, SL; Lu, SN; Wang, LY; Yuan, Y; L'Italien, G; Chien, KL; Chen, CJ | Kidney international 92(3), 703-709 | |||
22 | 2017 | Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance | Huang, CF; Yeh, ML; Huang, CI; Lin, YJ; Tsai, PC; Lin, ZY; Chan, SY; Chen, SC; Yang, HI; Huang, JF; Lu, SN; Dai, CY; Jen, CL; Yuan, Y; L'Italien, G; Wang, LY; Lee, MH; Yu, ML; Chuang, WL; Chen, CJ | Oncotarget 8(27), 43925-43933 | |||
23 | 2017 | Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers | Chu, YJ; Yang, HI; Wu, HC; Liu, J; Wang, LY; Lu, SN; Lee, MH; Jen, CL; You, SL; Santella, RM; Chen, CJ | International journal of cancer 141(4), 711-720 | |||
24 | 2017 | Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients | Liu, J; Hu, HH; Lee, MH; Korenaga, M; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; Mizokami, M; Chen, CJ ; Yang, HI | Scientific reports 7, 14352 | |||
25 | 2016 | Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression. | Liu, J; Yang, HI ; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Chen, CJ | HEPATOLOGY 64(2), 381-389 | |||
26 | 2016 | The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. | Hu, HH; Liu, J; Lin, YL; Luo, WS; Chu, YJ; Chang, CL; Jen, CL; Lee, MH; Lu, SN; Wang, LY; You, SL; Yang, HI ; Chen, CJ | Gut 65, 1514-1521 | |||
27 | 2016 | Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis | Chien, J; Liu, J; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Yang, HI ; Chen, CJ | Journal of gastroenterology and hepatology 31(12), 1971-1977 | |||
28 | 2016 | Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study. | Lin, YJ; Shaw, TG; Yang, HI ; Lu, SN; Jen, CL; Wang, LY; Wong, KH; Chan, SY; Yuan, Y; L'Italien, G; Chen, CJ ; Lee, MH | Liver international 37(2), 179-186 | |||
29 | 2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang, HI ; Tseng, TC; Liu, J; Lee, MH; Liu, CJ; Su, TH; Batrla-Utermann, R; Chan, HL; Kao, JH; Chen, CJ | Clinical gastroenterology and hepatology 14(3), 461-468.e2 | |||
30 | 2016 | Mediation effect of hepatitis B and C on mortality. | Huang, YT ; Freeman, JR; Yang, HI ; Liu, J; Lee, MH; Chen, CJ | European journal of epidemiology 31(6), 625-33 | |||
31 | 2016 | Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma. | Liu, J; Yang, HI ; Lee, MH; Jen, CL; Hu, HH; Lu, SN; Wang, LY; You, SL; Huang, YT ; Chen, CJ | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 25(4), 693-9 |